menu
    • menu

    Company profile for Mogrify

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Mogrify has developed a proprietary direct cellular conversion technology, which makes it possible to transform (transmogrify) any mature human cell type into any other without going through a pluripotent stem cell- or progenitor cell-state. Leveraging data from next-generation sequencing & regulatory networks (DNA-protein & protein-protein), the platform takes a systematic big-data approach to identify the transcription facto...
    Mogrify has developed a proprietary direct cellular conversion technology, which makes it possible to transform (transmogrify) any mature human cell type into any other without going through a pluripotent stem cell- or progenitor cell-state. Leveraging data from next-generation sequencing & regulatory networks (DNA-protein & protein-protein), the platform takes a systematic big-data approach to identify the transcription factors (in vitro) or small molecules (in vivo), needed to convert a cell. By bypassing the stem cell-stage of cell transformation, Mogrify simultaneously addresses challenges associated with efficacy, safety & scalability.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Mogrifyunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    25 Cambridge Science Park Milton Road Cambridge CB4 0FW
    Telephone
    Telephone
    + 44 (0)1223 734154
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://mogrify.co.uk/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mogrify-developing-next-generation-cell-therapies/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Mogrify_UK

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mogrify Appoints Dr Jonathan Appleby as Chief Scientific Officer
    Mogrify Appoints Dr Jonathan Appleby as Chief Scientific Officer

    15 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240715032498/en

    BUSINESSWIRE
    15 Jul 2024
    Share Share
    Mogrify, Astellas collaborate for research on in vivo regenerative medicine
    Mogrify, Astellas collaborate for research on in vivo regenerative medicine

    05 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220705005349/en

    BUSINESSWIRE
    05 Jul 2022
    Share Share
    Mogrify Appoints Louise Modis as Chief Scientific Officer
    Mogrify Appoints Louise Modis as Chief Scientific Officer

    05 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211005005528/en

    BUSINESSWIRE
    05 Oct 2021
    Share Share
    Mogrify Enters Research Collaboration with MRC LMB
    Mogrify Enters Research Collaboration with MRC LMB

    11 Jan 2021

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2021-01-11/mogrify-enters-research-collaboration-with-mrc-lmb/

    CONTRACTPHARMA
    11 Jan 2021
    Share Share
    Mogrify Raises Additional $16 Million to Advance its Mission to Transform the Development of Life-saving Cell Therapies
    Mogrify Raises Additional $16 Million to Advance its Mission to Transform the Development of Life-saving Cell Therapies

    14 Oct 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20191014005257/en

    BUSINESSWIRE
    14 Oct 2019
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search